CPG
AMED

Cornerstone Planning Group’s Amedisys AMED Stock Holding History

Cornerstone Planning Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37
Closed -$3.67K – 1698
2025
Q2 		$3.67K Buy
+37
New +$3.5K ﹤0.01% 796
2024
Q4 		– Sell
-5
Closed -$477 – 1404
2024
Q3 		$477 Sell
5
-16
-76% -$1.56K ﹤0.01% 1096
2024
Q2 		$2.05K Sell
21
-67
-76% -$6.22K ﹤0.01% 760
2024
Q1 		$8.1K Sell
88
-34
-28% -$3.19K ﹤0.01% 444
2023
Q4 		$11.6K Hold
122
– – ﹤0.01% 402
2023
Q3 		$11.4K Sell
122
-126
-51% -$11.6K ﹤0.01% 396
2023
Q2 		$22.7K Buy
+248
New +$20.3K 0.01% 406
2022
Q4 		$26.6K Buy
+283
New +$25.5K 0.01% 373

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cornerstone Planning Group's AMED Position: Q3 2025 in Review

Cornerstone Planning Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 37 shares — an estimated $3.67K sold.

Cornerstone Planning Group first reported a position in AMED in Q4 2022 and held it in 8 quarters. The position peaked at $26.6K in Q4 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cornerstone Planning Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 37 Amedisys shares in Q3 2025, an estimated $3.67K.
  • Cornerstone Planning Group first reported a position in Amedisys in Q4 2022 and held it in 8 quarters.
  • Cornerstone Planning Group's Amedisys position peaked at $26.6K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cornerstone Planning Group's 13F filing for Q3 2025, filed 4 Nov 2025.